Michael Thomas Kolodychak, DMD

Michael Kolodychak practices at Armanini, Kolodychak, & Basile in Erie, Pennsylvania.

Michael Kolodychak's NPI, 1376519181, was assigned on February 23, 2006. Michael Kolodychak holds Pennsylvania license DS029985L.

Michael Kolodychak's primary practice is Armanini, Kolodychak, & Basile, at 4600 Zuck Rd, Erie, PA 16506-4932. The practice phone is (814) 838-2144.

Michael Kolodychak's primary practice is Armanini, Kolodychak, & Basile in Erie, Pennsylvania. Michael Kolodychak is also affiliated with UPMC Hamot. Dmand AI also links Michael Kolodychak to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Kolodychak practices, 2 sites in all. Vendor and product names are available with a free account.

Oral and maxillofacial surgery is Michael Kolodychak's primary specialty in the NPI Registry, under taxonomy code 204E00000X. Michael Kolodychak is licensed in Pennsylvania.

CMS data shows 12 Medicare services from Michael Kolodychak across 1 procedure code in 2023, for 13 Medicare patients. Medicare paid $765 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 13 Medicare patients who saw Michael Kolodychak in 2024. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Kolodychak's median patient age at 34, with 50% women.

In 2024, Michael Kolodychak wrote 223 Medicare Part D claims for 145 patients. 100% of them were for generic drugs. CMS names the drug for 183 of them, across 5 drugs with 11 or more claims each, at $560 in total drug cost. In 2023, CMS named 172 claims across 5 drugs.

Michael Kolodychak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 27 general payments to Michael Kolodychak from 8 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Nobel Biocare USA paid the most, $227.